Atherosclerosis: Conventional intake of cardiovascular drugs versus delivery using nanotechnology - A new chance for causative therapy?
Groner, Jonas, Göpferich, Achim and Breunig, Miriam
(2021)
Atherosclerosis: Conventional intake of cardiovascular drugs versus delivery using nanotechnology - A new chance for causative therapy?
Journal of Controlled Release 333, pp. 539-559.
Date of publication of this fulltext: 16 Apr 2021 09:07
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Journal of Controlled Release | ||||
| Publisher: | Elsevier | ||||
|---|---|---|---|---|---|
| Place of Publication: | AMSTERDAM | ||||
| Volume: | 333 | ||||
| Page Range: | pp. 539-559 | ||||
| Date | 2021 | ||||
| Institutions | Chemistry and Pharmacy > Institute of Pharmacy > Pharmaceutical Technology (Prof. Göpferich) | ||||
| Identification Number |
| ||||
| Keywords | LOW-DENSITY-LIPOPROTEIN; MEDIATED LOX-1 EXPRESSION; ARTERY ENDOTHELIAL-CELLS; ACTIVATED RECEPTOR-GAMMA; LOW-DOSE ASPIRIN; UP-REGULATION; ADHESION MOLECULE-1; GLOBAL BURDEN; OXIDIZED-LDL; RISK-FACTORS | ||||
| Dewey Decimal Classification | 600 Technology > 615 Pharmacy | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 45557 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric